aTYR PHARMA INC

ATYR · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.1B · 58 employees
225
SEC Filings
$0.363
Close 2026-09-18
58
Employees

Business Summary

aTyr Pharma is a clinical-stage biotechnology company that translates tRNA synthetase biology into therapies for fibrosis and inflammation. Its lead candidate, efzofitimod, is a novel biologic immunomodulator in clinical development for interstitial lung disease (ILD), including pulmonary sarcoidosis and SSc-ILD. The company also has two preclinical candidates, ATYR0101 and ATYR0750, targeting fibrotic diseases, and a collaboration with Kyorin Pharmaceutical for efzofitimod development in Japan.

Latest Stock Quote

ATYR 2026-09-18 $0.363 O:$0.37 H:$0.388 L:$0.36 Vol:1.3M VWAP:$0.3653
origin leaf: null

Next Earnings

expected 2026-12-24

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001339970-26-000008EDGAR79K words
2025-03-132024-12-310000950170-25-038888EDGAR76K words
2024-03-142023-12-310000950170-24-031584EDGAR76K words
2023-03-142022-12-310000950170-23-007873EDGAR80K words
2022-03-152021-12-310001564590-22-010441EDGAR—
2021-03-242020-12-310001564590-21-014940EDGAR—
2020-03-262019-12-310001564590-20-013208EDGAR—
2019-03-262018-12-310001564590-19-009381EDGAR—
2018-03-202017-12-310001564590-18-006333EDGAR—
2017-03-162016-12-310001564590-17-004631EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-072026-06-300001339970-26-000053EDGAR55K words
2025-11-062025-09-300001193125-25-269587EDGAR53K words
2025-08-072025-06-300001339970-25-000009EDGAR52K words
2025-05-072025-03-310000950170-25-065640EDGAR50K words
2024-11-072024-09-300000950170-24-123305EDGAR51K words
2024-08-132024-06-300000950170-24-096185EDGAR50K words
2024-05-022024-03-310000950170-24-052092EDGAR49K words
2023-11-092023-09-300000950170-23-062058EDGAR52K words
2023-08-092023-06-300000950170-23-040598EDGAR51K words
2023-05-092023-03-310000950170-23-019686EDGAR50K words
2022-11-142022-09-300000950170-22-024724EDGAR—
2022-08-152022-06-300000950170-22-017401EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-240001339970-26-000065EDGAR1K words
2026-08-070001339970-26-000051EDGAR3K words
2026-07-310001339970-26-000042EDGAR4K words
2026-03-050001339970-26-000006EDGAR3K words
2025-12-050001193125-25-309619EDGAR1K words
2025-11-060001193125-25-269486EDGAR3K words
2025-09-150001193125-25-202865EDGAR2K words
2025-08-070001339970-25-000007EDGAR2K words
2025-05-070000950170-25-065611EDGAR2K words
2025-05-060000950170-25-064413EDGAR10K words

225 total filings indexed. 193 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

interstitial-lung-disease pulmonary-sarcoidosis systemic-sclerosis-associated-ild fibrosis inflammation rare/orphan-diseases

Company Identity

CIK0001339970
TickerATYR
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.atyrpharma.com
Listed2015-05-07

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 6109bff96b006013da677767160e258a0bd1a7bc5c73b128ab534f853cbf7285
parent: e431a2b1f59649edec20535c41488fe48509da864cf03ff9c8e0596c9b7d04a3
content hash: 38acb2b49fa2171ade41e0cfc6d0a0be0eb19884b829bfc63f4b8dfd3017ef6f
signed: 2026-09-29T12:00:25.356Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ATYR using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ATYR, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ATYR (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.